Skip to main content
CNXC
NASDAQ Trade & Services

Concentrix Books $1.05B Goodwill Impairment, Swings to $988M Q3 Loss; Non-GAAP EPS Tops Views

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: IT Services Stocks · Technology
Sentiment info
Negative
Importance info
8
Price
$24.6
Mkt Cap
$1.518B
52W Low
$19.12
52W High
$49.37
52W Position info
29% above low
Off High info
50% below high
Rel. Volume info
1.8× avg
Market data snapshot near publication time

CNXC sits 29% above its 52-week low of $19.12.

Summary

A $1.05B goodwill impairment charge drove a $988M Q3 GAAP loss, while non-GAAP EPS of $2.92 beat expectations and the company raised its dividend. Q3 revenue fell 1.2% to $2.45B, with 50% of revenue now from business won in the last 3 years.

Updated with a Reuters report · What changed

Updates

  1. · Reuters — Q3 adjusted EPS rose 5% to $2.92, and 2026 revenue is forecast at $9.83 billion to $9.88 billion.

    • Earnings — Adjusted EPS for Q3 rose 5% year-over-year to $2.92.
    • Goodwill Impairment — The non-cash goodwill impairment charge was $1.05 billion.
    • New Business Impact — New business won in the last 3 years contributed to margin expansion and strong free cash flow; 50% of revenue now comes from business won and deployed in the last 3 years since the introduction of AI.
    • Sector Performance — Q3 revenue declined in technology, consumer electronics, communications, media, and healthcare sectors, but grew in banking, financial services, insurance, retail, travel, and e-commerce sectors.
    • 2026 Forecast — Concentrix forecasts 2026 revenue of $9.83 billion to $9.88 billion.
    All 8 details
    • Adjusted EPS for Q3 rose 5% year-over-year.
    • The non-cash goodwill impairment charge was $1.05 billion.
    • New business won in the last 3 years contributed to margin expansion and strong free cash flow.
    • Q3 revenue declined in technology, consumer electronics, communications, media, and healthcare sectors.
    • Q3 revenue grew in banking, financial services, insurance, retail, travel, and e-commerce sectors.
    • Q3 Adjusted EPS was $2.92.
    • Concentrix forecasts 2026 revenue of $9.83 billion to $9.88 billion.
    • 50% of revenue now comes from business won and deployed in the last 3 years since the introduction of AI

Key Events · Earnings and Guidance · CNXC

  • New · · Reuters

    Q3 Revenue Falls 1.2% to $2.45B

    Q3 revenue fell 1.2% to $2.45B, with 50% of revenue now from business won in the last 3 years. Revenue declined in technology, consumer electronics, communications, media, and healthcare sectors, while growing in banking, financial services, insurance, retail, travel, and e-commerce sectors.

  • New · · Reuters

    New Business Drives Margin and Cash Flow

    New business won in the last 3 years contributed to margin expansion and strong free cash flow.

  • Updated · · Reuters

    Non-GAAP EPS Beats at $2.92

    Non-GAAP operating income rose 1.3% to $309.0M (12.6% margin), non-GAAP net income was $186.5M, and adjusted EBITDA was $363.0M. Adjusted EPS for Q3 rose 5% year-over-year to $2.92.

  • Updated · · Reuters

    Q4 and FY2026 Guidance

    Q4 non-GAAP EPS guided to $2.86-$2.98 on revenue of $2.410B-$2.460B; full-year non-GAAP EPS of $10.97-$11.09 and adjusted free cash flow of $630M-$650M. Concentrix forecasts 2026 revenue of $9.83 billion to $9.88 billion.

  • $1.05B Goodwill Impairment Charge

    Non-cash impairment primarily driven by the trading range of the company's stock price and market capitalization, reducing goodwill from $3.67B to $2.64B.

  • Q3 GAAP Loss of $988M

    GAAP diluted EPS of $(16.24) versus $1.34 a year ago, driven entirely by the impairment charge; operating margin fell to (37.1)%.


Analysis · CNXC · Trade & Services

A $1.05 billion non-cash goodwill impairment charge, driven by the company's depressed stock price and market capitalization, pushed Q3 GAAP results to a $988 million net loss and $(16.24) diluted EPS. The charge erases roughly 60% of the company's $1.77 billion stockholders' equity and signals management's acknowledgment that prior acquisition values are no longer supported by the market. Against that backdrop, the underlying business showed resilience: non-GAAP operating income rose 1.3% to $309 million, non-GAAP EPS of $2.92 beat the prior year's $2.78, and record adjusted free cash flow of $218 million supports the dividend increase to $0.37 per share. Q3 revenue fell 1.2% to $2.45 billion, with 50% of revenue now coming from business won and deployed in the last 3 years since the introduction of AI; revenue declined in technology, consumer electronics, communications, media, and healthcare sectors, while growing in banking, financial services, insurance, retail, travel, and e-commerce sectors. The company guided Q4 non-GAAP EPS to $2.86-$2.98 and full-year adjusted free cash flow to $630-$650 million, but revenue is expected to decline 3-5% on a constant currency basis, reflecting continued pressure in technology and healthcare verticals. Concentrix forecasts 2026 revenue of $9.83 billion to $9.88 billion.

How filings like this one have moved

In the 30 days to Oct 1, 2026, 36.1% of the 1052 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.56%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, CNXC was trading at $24.60 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $1.5B. The 52-week trading range was $19.12 to $49.37. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CNXC - Latest Insights

CNXC
Sep 29, 2026, 4:05 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $25.00
Real-time Price: $24.97 info
Change: -$0.030 (-0.12%) info
Market Cap: $1.522B info
CNXC
Sep 08, 2026, 4:30 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $28.27
Real-time Price: $24.97 info
Change: -$3.30 (-12%) info
Market Cap: $1.522B info
CNXC
Jul 02, 2026, 8:11 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $23.20
Real-time Price: $24.97 info
Change: +$1.77 (+8%) info
Market Cap: $1.522B info
CNXC
Jul 02, 2026, 8:02 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $23.20
Real-time Price: $24.97 info
Change: +$1.77 (+8%) info
Market Cap: $1.522B info
CNXC
Jun 29, 2026, 4:16 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $18.92
Real-time Price: $24.97 info
Change: +$6.05 (+32%) info
Market Cap: $1.522B info